Nuzenio

Innovation Passport

Innovation Passport news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 8 publisher sources 100/100 entity strength

Latest news

UK ILAP Grants Innovation Passports to BeOne's Liver Cancer Therapy & CervoMed's Dementia Candidate - NAVLIN DAILYNAVLIN DAILY · Fri, 07 Aug 2026 08:42:41 GMTCervoMed granted Innovation Passport for neflamapimod in UK - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 13:17:34 GMTBeOne Medicines secures UK innovation passport for HCC therapy - PharmaTimesPharmaTimes · Wed, 05 Aug 2026 09:59:35 GMTInnovation Passports for Liver Cancer and Dementia Treatm... - politicsuk.compoliticsuk.com · Wed, 05 Aug 2026 08:04:23 GMTCervoMed granted UK Innovation Passport for neflamapimod in dementia with Lewy bodies - TradingViewTradingView · Tue, 04 Aug 2026 11:53:00 GMTCervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 09:15:00 GMTThe Innovative Licensing and Access Pathway grants Innovation Passports to investigational products for cancer and dementia - GOV.UKGOV.UK · Tue, 04 Aug 2026 08:56:29 GMTCervoMed says UK grants ILAP Innovation Passport for neflamapimod in Lewy body dementia - BitgetBitget · Tue, 04 Aug 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 08:42:41 GMTUK ILAP Grants Innovation Passports to BeOne's Liver Cancer Therapy & CervoMed's Dementia Candidate - NAVLIN DAILY
Wed, 05 Aug 2026 13:17:34 GMTCervoMed granted Innovation Passport for neflamapimod in UK - The Pharma Letter
Wed, 05 Aug 2026 09:59:35 GMTBeOne Medicines secures UK innovation passport for HCC therapy - PharmaTimes
Wed, 05 Aug 2026 08:04:23 GMTInnovation Passports for Liver Cancer and Dementia Treatm... - politicsuk.com
Tue, 04 Aug 2026 11:53:00 GMTCervoMed granted UK Innovation Passport for neflamapimod in dementia with Lewy bodies - TradingView
Tue, 04 Aug 2026 09:15:00 GMTCervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB) - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Innovation Passport.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.